Xencor

-$0.22 (-0.98%) Today

$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.

CEO

Bassil I. Dahiyat

Employees

254

Headquarters

Monrovia, California

Founded

1997

XNCR Key Statistics

Market cap

Price-Earnings ratio

12.65

Dividend yield

—

Average volume

314.44K

High today

$23.07

Low today

$22.05

Open price

$22.42

Volume

222.45K

52 Week high

$43.61

52 Week low

$21.98

XNCR News

Simply Wall StMay 24

Shareholders in Xencor have lost 42%, as stock drops 3.7% this past week - Simply Wall St

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory retu

Analyst ratings

Buy

93.3%

Hold

Sell

6.7%

XNCR Earnings

-$0.69

-$0.06

$0.58

$1.21

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 4, After Hours

Why Robinhood?

Shareholders in Xencor have lost 42%, as stock drops 3.7% this past week - Simply Wall St

93%